50Wire
Oklahoma accused Johnson & Johnson of "blaming everyone except themselves" during closing arguments Monday in the state's $17.5 billion bellwether opioid crisis trial, saying the... [Read More]
Searching for "Drugmaker" 
4 hr ago Newsmax
U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV, news that lifted Galapagos's... [Read More]
4 hr ago Reuters
U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV , news that... [Read More]
Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson to a drug cartel leader as they sought to hold the drugmaker responsible... [Read More]
Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson to a drug cartel leader as they sought to hold the drugmaker responsible... [Read More]
1:58 PM Reuters
The biotech giant is spending $5.1 billion on Belgian outfit Galapagos but won't take control. That, says Robert Cyran, means Gilead can profit from the... [Read More]
Oklahoma Attorney General Mike Hunter has described consumer products giant Johnson & Johnson as the "kingpin" company that helped fuel the state's opioid crisis during... [Read More]
NORMAN, Okla., July 15- Lawyers for the state of Oklahoma on Monday compared Johnson& Johnson to a drug cartel leader as they sought to hold... [Read More]
Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson to a drug cartel leader as they sought to hold the drugmaker responsible... [Read More]
Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson to a drug cartel leader as they sought to hold the drugmaker responsible... [Read More]
The Latest on Oklahoma's lawsuit against consumer products giant Johnson & Johnson and its subsidiaries over the opioid crisis (all times local): 9:25 a.m.... [Read More]
The Latest on Oklahoma's lawsuit against consumer products giant Johnson & Johnson and its subsidiaries over the opioid crisis (all times local):... [Read More]
David Schenkein led Agios Pharmaceuticals from its early days in 2009 through the beginning of 2019. He joined Alphabet's venture arm GV as a... [Read More]
8:41 AM Reuters
U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV . [Read More]
6:48 AM Reuters
U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV , news that... [Read More]
3:26 AM Reuters
British drugmaker AstraZeneca Plc said on Monday the U.S. Food and Drug Administration declined to approve its diabetes treatment, Farxiga, for use as a... [Read More]
3:07 AM Reuters
British drugmaker AstraZeneca Plc said on Monday the U.S. Food and Drug Administration declined to approve its diabetes treatment, Farxiga, for use as a... [Read More]
2:31 AM Reuters
British drugmaker AstraZeneca Plc said on Monday the U.S. Food and Drug Administration declined to approve its diabetes treatment, Farxiga, for use as a... [Read More]
2:25 AM Reuters
British drugmaker AstraZeneca Plc said on Monday the U.S. Food and Drug Administration declined to approve its diabetes treatment, Farxiga, for use as a... [Read More]
Powered By
